Systemic Availability and Lymphatic Transport of Human Growth Hormone Administered by Subcutaneous Injection
- 1 February 2000
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 89 (2) , 168-177
- https://doi.org/10.1002/(sici)1520-6017(200002)89:2<168::aid-jps4>3.0.co;2-q
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Bioavailability and bioactivity of three different doses of nasal growth hormone (GH) administered to GH-deficient patients: comparison with intravenous and subcutaneous administrationActa Endocrinologica, 1996
- Bioavailability and bioactivity of intravenous vs subcutaneous infusion of growth hormone in GH‐deficient patientsClinical Endocrinology, 1996
- Pharmacokinetics and Short-Term Metabolic Effects of Mammalian Cell-Derived Biosynthetic Human Growth Hormone in ManHormone Research, 1992
- Effect of Molecular Weight on the Lymphatic Absorption of Water-Soluble Compounds Following Subcutaneous AdministrationPharmaceutical Research, 1990
- Subcutaneous degradation of biosynthetic human growth hormone in growth hormone deficient patientsActa Endocrinologica, 1988
- Recombinant Human Interferon Alpha-2a: Delivery to Lymphoid Tissue by Selected Modes of ApplicationPharmaceutical Research, 1988
- Serum profiles and short-term metabolic effect of pituitary and authentic biosynthetic human growth hormone in manActa Endocrinologica, 1987
- Increased growth rate following transfer to daily sc administration from three weekly im injections of hGH in growth hormone deficient childrenActa Endocrinologica, 1983
- STUDIES ON THE PERMEABILITY OF LYMPHATIC CAPILLARIESThe Journal of cell biology, 1971
- THE OUTPUT OF CELLS IN LYMPH FROM THE POPLITEAL NODE OF SHEEPQuarterly Journal of Experimental Physiology and Cognate Medical Sciences, 1962